Data from two studies suggest that a once-daily combination therapy of doravirine and islatravir was noninferior to current, ...

"Importantly, islatravir dosed at a daily dose of 0.25 mg did not adversely ... inferior to either BIC/FTC/TAF or oral ART, providing a daily, single-tablet alternative to those who require ...

once-daily DOR/ISL (100mg/0.25mg) in adults with HIV-1 infection that has been virologically suppressed on BIC/FTC/TAF (50mg/200mg/25mg). The primary efficacy endpoint was the percentage of ...

Gilead Sciences, Inc. today announced the presentation of late-breaking data and multiple oral presentations from its innovative HIV treatment portfolio and pipeline at the Conference on Retroviruses ...

The ALLIANCE trial is the first randomized clinical trial of TAF- vs TDF-based regimens in ... mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg) is indicated as a complete regimen for the ...

Antiviral therapy with a once-daily single-tablet regimen of doravirine plus islatravir ... Switch to DOR/ISL (100/0.25 mg) QD from BIC/FTC/TAF: A blinded phase III study in adults with HIV-1.

That means you can sync content across all your devices from computers through to tablets and phones. In other words, if you start a task on one device, you can complete it on another. With ...

There are some great tablets that are priced under Rs. 20,000 in India, and this list shows you those models that are currently available in the country, with the latest launched tablet shown first.

It is one of the world's largest vendors of personal computers. The company also makes other products such as tablets, storage devices, smartphones, servers, televisions (LCD and LED), apart from ...